Exagen Inc (XGN) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $3.80
• Market Cap: $86.12M
• EPS: $-0.93
• 52-Week High: $12.23
• 52-Week Low: $2.67

Market Sentiment

Exagen Inc currently has a Neutral sentiment score of -0.02.

About Exagen Inc

Exagen Inc. is a pioneering biotechnology company based in Vista, California, specializing in diagnostic solutions for autoimmune diseases utilizing its proprietary Cell-Bound Complement Activation Products technology, known as AVISE. Committed to improving patient care, Exagen offers innovative diagnostic tests that facilitate precise diagnosis and management of complex conditions like lupus and various inflammatory diseases. Through a strong focus on clinical validation and innovation, the ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Exagen Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does XGN pay dividends?

Exagen Inc (XGN) does not currently pay a regular dividend.

What is XGN's market cap?

Exagen Inc (XGN) has a market capitalization of $86.12M with a current stock price of $3.80.